Form 4: Personalis Inc. Executive Acquires 250,000 Stock Options
SEC Form 4 Filing
Richard Chen, Chief Medical Officer and EVP of Personalis, Inc., acquired 250,000 stock options on March 15, 2025, exercisable at $3.63.
Summary
- Richard Chen, the Chief Medical Officer and EVP of Personalis, Inc. (PSNL), filed a Form 4 indicating a change in beneficial ownership.
- On March 15, 2025, Chen acquired 250,000 stock options with an exercise price of $3.63.
- These options vest in 36 equal monthly installments, starting on April 15, 2025.
- The options expire on March 15, 2035.
- Following the transaction, Chen directly owns 250,000 derivative securities (stock options).
Sentiment
Score: 6
Explanation: Neutral sentiment. The document is a standard regulatory filing related to executive compensation. It doesn't inherently indicate positive or negative performance, but rather provides transparency into insider transactions.
Positives
- An executive acquiring stock options can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders (officers, directors, and 10% owners) of a publicly traded company buy or sell the company's securities. This filing provides transparency into insider transactions.
Stakeholder Impact
- Shareholders may view insider transactions as a signal of management's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 03/15/2025 | Date of the stock option acquisition. |
| 04/15/2025 | First vesting date of the stock options. |
| 03/15/2035 | Expiration date of the stock options. |
| 03/18/2025 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.